Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.

Bastiaan M PrivéMarcel J R JanssenInge M van OortConstantijn H J MuselaersMarianne A JonkerWillemijn A van GemertMichel de GrootHarm WestdorpNiven MehraJ Fred VerzijlbergenTom W J ScheenenPatrik ZámecnikJelle O BarentszMartin GotthardtWalter NoordzijWouter V VogelAndries M BergmanHenk G van der PoelAndré N VisDaniela E Oprea-LagerWinald R GerritsenJ Alfred WitjesJames Nagarajah

Published in: Trials (2021)

ClinicalTrials.gov NCT04443062 . First posted: June 23, 2020.

Keyphrases

prostate cancer
pet ct
radical prostatectomy
squamous cell carcinoma
phase iii
study protocol
small cell lung cancer
pet imaging
clinical trial
phase ii
randomized controlled trial
positron emission tomography